CN115336746A - Medicinal and edible composition for health preservation - Google Patents
Medicinal and edible composition for health preservation Download PDFInfo
- Publication number
- CN115336746A CN115336746A CN202210962729.1A CN202210962729A CN115336746A CN 115336746 A CN115336746 A CN 115336746A CN 202210962729 A CN202210962729 A CN 202210962729A CN 115336746 A CN115336746 A CN 115336746A
- Authority
- CN
- China
- Prior art keywords
- parts
- composition
- raw material
- following raw
- salvia miltiorrhiza
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 230000036541 health Effects 0.000 title claims description 22
- 238000004321 preservation Methods 0.000 title claims description 11
- 239000003814 drug Substances 0.000 claims abstract description 46
- 239000006187 pill Substances 0.000 claims abstract description 34
- 229940079593 drug Drugs 0.000 claims abstract description 24
- 239000002994 raw material Substances 0.000 claims abstract description 21
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 15
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 15
- 241001678082 Dendrobium huoshanense Species 0.000 claims abstract description 14
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 14
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 14
- 241000305491 Gastrodia elata Species 0.000 claims abstract description 7
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 6
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 6
- 235000013305 food Nutrition 0.000 claims description 18
- 238000002360 preparation method Methods 0.000 claims description 12
- 241000305492 Gastrodia Species 0.000 claims description 8
- 239000008678 sanqi Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 2
- 239000000463 material Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 10
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 206010020772 Hypertension Diseases 0.000 abstract description 8
- 239000008280 blood Substances 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 8
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 8
- 230000036039 immunity Effects 0.000 abstract description 8
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract description 7
- 230000001105 regulatory effect Effects 0.000 abstract description 7
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 201000001421 hyperglycemia Diseases 0.000 abstract description 6
- 206010008132 Cerebral thrombosis Diseases 0.000 abstract description 4
- 206010019233 Headaches Diseases 0.000 abstract description 4
- 201000001429 Intracranial Thrombosis Diseases 0.000 abstract description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 4
- 210000004204 blood vessel Anatomy 0.000 abstract description 4
- 230000007812 deficiency Effects 0.000 abstract description 4
- 208000002173 dizziness Diseases 0.000 abstract description 4
- 231100000869 headache Toxicity 0.000 abstract description 4
- 206010022437 insomnia Diseases 0.000 abstract description 4
- 210000002784 stomach Anatomy 0.000 abstract description 4
- 230000008961 swelling Effects 0.000 abstract description 4
- 206010002383 Angina Pectoris Diseases 0.000 abstract description 3
- 208000002193 Pain Diseases 0.000 abstract description 3
- 230000036772 blood pressure Effects 0.000 abstract description 3
- 206010008118 cerebral infarction Diseases 0.000 abstract description 3
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 3
- 230000004438 eyesight Effects 0.000 abstract description 3
- 239000012530 fluid Substances 0.000 abstract description 3
- 206010019847 hepatosplenomegaly Diseases 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 231100000862 numbness Toxicity 0.000 abstract description 3
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
- 235000005911 diet Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 3
- 208000034783 hypoesthesia Diseases 0.000 description 3
- 208000004044 Hypesthesia Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 235000007328 Hericium erinaceus Nutrition 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 208000027530 Meniere disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 201000002451 Overnutrition Diseases 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000021409 diet quality Nutrition 0.000 description 1
- 235000005118 dietary health Nutrition 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000020823 overnutrition Nutrition 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses a health-preserving medicinal and edible composition, which consists of the following raw material medicines in parts by weight: 15-25 parts of pseudo-ginseng, 15-25 parts of salvia miltiorrhiza, 15-25 parts of dendrobium huoshanense, 15-25 parts of American ginseng and 15-25 parts of gastrodia elata. The composition wucao pill has the effects of tonifying qi, refreshing, promoting blood circulation, removing obstruction in channels, relieving swelling, relieving pain, nourishing stomach, nourishing yin, clearing heat, promoting fluid production, improving eyesight, reducing blood pressure, regulating blood sugar, improving immunity and the like, can prevent cerebral infarction, hypertension, hyperglycemia, hyperlipidemia, diabetes, headache, dizziness, limb numbness, body deficiency, angina, cerebral thrombosis, insomnia, hepatosplenomegaly, blood vessel blockage, rheumatoid arthritis and the like, is suitable for various crowds, is orally taken when being used, and is recommended to be taken twice a day, and 30 pills are taken each time.
Description
Technical Field
The invention relates to a medicinal and edible composition for health preservation, and belongs to the technical field of dietary health preservation.
Background
With the development of society and the improvement of living standard, the diet quality of people is continuously improved, but the problem of overnutrition is brought, and the people are easy to suffer from diseases with high price. The term "disease of abundance" refers to a disease related to metabolism, particularly to a disease caused by excess nutrition, and the common diseases of abundance include diabetes, hypertension, hyperlipidemia, hyperuricemia, obesity, and apnea syndrome. Therefore, how to prevent the diseases is a problem which needs to be solved urgently.
Diet health preservation is an important traditional theory of Chinese medicine in China, and extremely rich experience is accumulated in long-term practice. It is stated that: the medicine is better than food, people can not eat three meals a day in daily life, diet is scientifically and reasonably prepared, effects of nourishing and preserving health, improving immunity and preventing diseases can be achieved, and the health is benefited.
Homology of medicine and food is a theory existing in Chinese medicine since ancient times, and the theory is considered as follows: many foods are both food and drugs, and food and drugs, like drugs, can also prevent and treat diseases. In ancient primitive society, people found the nature, taste and efficacy of various foods and medicines in the process of searching for foods, and realized that many foods can be used as medicines and many medicines can be eaten, and the two are difficult to be strictly distinguished. The theory of homology of medicine and food is the basis of the food therapy.
Although Chinese medicine accumulates very rich diet health experience and leaves a plurality of precious health-preserving formulas, ancient diseases are not common, so that no effective health-preserving formula is left for the diseases. Under the guidance of the Chinese traditional medicine diet health preserving theory, medicine and food homology theory and other theories, a health preserving formula capable of effectively preventing the rich diseases is researched, not only can the inheritance of the Chinese traditional medicine theory be reflected, but also the characteristics of continuous development and advancement of the Chinese traditional medicine theory can be reflected, and the health preserving formula has important significance.
Disclosure of Invention
Aiming at the prior art, the invention provides a composition for health preservation, namely a wucao pill, which has the effects of nourishing, preserving health and enhancing immunity, and can effectively prevent diseases, in particular to rich and noble diseases such as hypertension, hyperlipidemia, hyperglycemia, diabetes and the like.
The invention is realized by the following technical scheme:
a composition used as both medicine and food for health preservation, wu cao wan, is composed of the following raw material medicines in parts by weight: 15-25 parts of Yunnan pseudo-ginseng, 15-25 parts of purple salvia miltiorrhiza, 15-25 parts of dendrobium huoshanense, 15-25 parts of American ginseng and 15-25 parts of gastrodia elata.
Preferably, the traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 20 parts of Yunnan pseudo-ginseng, 20 parts of salvia miltiorrhiza bunge, 20 parts of dendrobium huoshanense, 20 parts of American ginseng and 20 parts of gastrodia elata.
The preparation method of the wucao pill comprises the following steps: the raw materials are mixed, crushed and pressed into pills, and the pills are obtained, wherein the weight of the pills is 1000 pills/125 grams. In order to have better taste or better shaping, proper adjuvants such as magnesium stearate, water, mel, syrup, wine, vinegar, etc. can be added during making into pill.
The wucao pill of the invention has the following effects of the raw material medicines:
1. wen san qi (wenshan lion head): promoting blood circulation, removing blood stasis, dredging blood vessel, improving blood consistency, regulating hypertension, hyperglycemia and hyperlipidemia, relieving fatigue, resisting aging, and improving organism immunity.
2. Radix Salviae Miltiorrhizae (Yunnan Zhaotong wild radix Salviae Miltiorrhizae): promoting blood circulation, removing blood stasis, cooling blood, relieving swelling, improving cardiac function, promoting cardiovascular and cerebrovascular circulation, regulating heart rhythm, and enhancing myocardial contraction rate.
3. Dendrobe (jojoba): nourishing stomach and yin, protecting liver, brightening eyes, regulating blood sugar, preventing and treating diabetes, preventing and resisting cancer, and has remarkable curative effect on people with excessive smoking and drinking.
4. American ginseng (imported canada): has effects in invigorating qi, refreshing, clearing away heat, promoting salivation, improving thinking, regulating endocrine, and enhancing immunity, and can be used for treating deficiency of qi and yin, internal heat, diabetes, xerostomia, dry throat, and excessive deficient fire.
5. Gastrodia elata (yunnan zhaotong pharmacodynamic king): nourishing kidney and brain, calming liver to stop wind, dispelling pathogenic wind and dampness, and can be used for treating headache, dizziness, hypertension, cerebral thrombosis, insomnia, neurasthenia, numbness of limbs, rheumatism, asthenia, qi and blood circulation promoting, aural vertigo, infantile convulsion and epilepsy.
The wucao pill has the effects of tonifying qi, refreshing, activating blood circulation, dredging collaterals, relieving swelling and pain, nourishing stomach, nourishing yin, clearing heat, promoting fluid production, improving eyesight, reducing blood pressure, regulating blood sugar, improving immunity and the like, can prevent cerebral infarction, hypertension, hyperglycemia, hyperlipidemia, diabetes, headache, dizziness, limb numbness, body deficiency, angina, cerebral thrombosis, insomnia, hepatosplenomegaly, blood vessel blockage, rheumatoid arthritis and the like, is suitable for various crowds, is orally taken when being used, is recommended to be taken twice a day, is 30 pills each time, and is best to be slowly stepped for 2000-3000 steps after being taken. It should be noted that the wu cao wan of the present invention is a primary product of agricultural and sideline products, and can not be used as a substitute for drugs, and patients suffering from diseases should take the wu cao wan of the present invention reasonably and properly when allowed by doctors.
The wucao pill is a formula researched under the guidance of Chinese medicinal diet health preserving and medicine-food homology theories, has the effects of nourishing, health preserving and immunity enhancing, can effectively prevent diseases, particularly rich and noble diseases such as hypertension, hyperlipidemia, hyperglycemia, diabetes and the like, and is safe and free of toxic and side effects.
Drawings
FIG. 1: test report 1.
FIG. 2: test report 2.
FIG. 3: test detection report 3.
FIG. 4: test detection report 4.
Detailed Description
The present invention will be further described with reference to the following examples. However, the scope of the present invention is not limited to the following examples. It will be understood by those skilled in the art that various changes and modifications may be made to the present invention without departing from the spirit and scope of the invention.
Example 1 preparation of wucao pill
The traditional Chinese medicine composition is prepared from the following raw material medicines: 5 kg of clouded pseudo-ginseng, 5 kg of salvia miltiorrhiza, 5 kg of dendrobium huoshanense, 5 kg of American ginseng and 5 kg of gastrodia elata.
The preparation method comprises the following steps: mixing the raw materials, pulverizing, sieving with 100 mesh sieve, and making into pill (1000 pills/125 g).
And (4) detecting the prepared product, wherein the detection is qualified and meets the relevant standards of food as shown in figures 1-4.
The wucao pill provided by the invention is prepared by combining various medicines, has the effects of tonifying qi and refreshing, activating blood circulation to remove meridian obstruction, reducing swelling and relieving pain, nourishing stomach and nourishing yin, clearing heat and promoting fluid production, improving eyesight, reducing blood pressure, regulating blood sugar, improving immunity and the like, can prevent cerebral infarction, hypertension, hyperglycemia, hyperlipidemia, diabetes, headache and dizziness, numbness of hands and feet, body deficiency angina, cerebral thrombosis, insomnia, hepatosplenomegaly, blood vessel blockage, rheumatoid arthritis and the like, is suitable for various crowds, is orally taken (convenient to carry during traveling) when being used, is recommended to be taken twice a day, is 30 pills every time, and is preferably slowly taken for 2000-3000 steps after being taken. It should be noted that the wu cao wan of the present invention is a primary product of agricultural and sideline products, and can not be used as a substitute for drugs, and patients suffering from diseases should take the wu cao wan of the present invention reasonably and properly when allowed by doctors.
Example 2 preparation of wucao pill
The traditional Chinese medicine composition is prepared from the following raw material medicines: yun Sanqi 150 g, salvia miltiorrhiza bunge 250 g, dendrobium huoshanense 150 g, american ginseng 250 g and gastrodia tuber 150 g.
The preparation method comprises the following steps: mixing the raw materials, pulverizing, and making into pill (1000 pills/125 g).
Example 3 preparation of wucao pill
The traditional Chinese medicine composition is prepared from the following raw material medicines: yun Sanqi 250 g, salvia miltiorrhiza 150 g, dendrobium huoshanense 250 g, american ginseng 150 g and gastrodia tuber 250 g.
The preparation method comprises the following steps: mixing the raw materials, pulverizing, and making into pill (1000 pills/125 g).
Example 4 preparation of wucao pill
The traditional Chinese medicine composition is prepared from the following raw material medicines: yun Sanqi 180 g, salvia miltiorrhiza 180 g, dendrobium huoshanense 220 g, american ginseng 220 g and gastrodia tuber 180 g.
The preparation method comprises the following steps: mixing the raw materials, pulverizing, and making into pill (1000 pills/125 g).
Example 5 preparation of wucao pill
The traditional Chinese medicine composition is prepared from the following raw material medicines: yun Sanqi 210 g, purple salvia miltiorrhiza 210 g, dendrobium huoshanense 190 g, american ginseng 190 g and gastrodia tuber 230 g.
The preparation method comprises the following steps: mixing the raw materials, pulverizing, and making into pill (1000 pills/125 g).
The above examples are provided to those of ordinary skill in the art to fully disclose and describe how to make and use the claimed embodiments, and are not intended to limit the scope of the disclosure herein. Modifications apparent to those skilled in the art are intended to be within the scope of the appended claims.
Claims (10)
1. A medicinal and edible composition for health preservation is characterized by comprising the following raw material medicines in parts by weight: 15-25 parts of pseudo-ginseng, 15-25 parts of salvia miltiorrhiza, 15-25 parts of dendrobium huoshanense, 15-25 parts of American ginseng and 15-25 parts of gastrodia elata.
2. The composition with homology of medicine and food for health preserving as claimed in claim 1 is characterized by comprising the following raw material medicines in parts by weight: 20 parts of Yunnan pseudo-ginseng, 20 parts of salvia miltiorrhiza bunge, 20 parts of dendrobium huoshanense, 20 parts of American ginseng and 20 parts of gastrodia elata.
3. The composition with homology of medicine and food for health preserving according to claim 1 is characterized by comprising the following raw material medicines: yun Sanqi 150 g, salvia miltiorrhiza bunge 250 g, dendrobium huoshanense 150 g, american ginseng 250 g and gastrodia tuber 150 g.
4. The composition with homology of medicine and food for health preservation according to claim 1 is characterized by being composed of the following raw material medicines: yun Sanqi 250 g, salvia miltiorrhiza 150 g, dendrobium huoshanense 250 g, american ginseng 150 g and gastrodia tuber 250 g.
5. The composition with homology of medicine and food for health preservation according to claim 1 is characterized by being composed of the following raw material medicines: yun Sanqi 180 g, salvia miltiorrhiza 180 g, dendrobium huoshanense 220 g, american ginseng 220 g and gastrodia tuber 180 g.
6. The composition with homology of medicine and food for health preservation according to claim 1 is characterized by being composed of the following raw material medicines: yun Sanqi 210 g, purple salvia miltiorrhiza 210 g, dendrobium huoshanense 190 g, american ginseng 190 g and gastrodia tuber 230 g.
7. The preparation method of the medicinal and edible composition for health preserving as claimed in any one of claims 1-6, is characterized in that: mixing the above materials, pulverizing, and making into pill.
8. The method of claim 7, wherein: and sieving the crushed mixture by a 100-mesh sieve.
9. The method of claim 7, wherein: the specification of the pill is as follows: 1000 pills/125 g.
10. The method of claim 7, wherein: the pressed pills are added with proper auxiliary materials.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210962729.1A CN115336746A (en) | 2022-08-11 | 2022-08-11 | Medicinal and edible composition for health preservation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210962729.1A CN115336746A (en) | 2022-08-11 | 2022-08-11 | Medicinal and edible composition for health preservation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115336746A true CN115336746A (en) | 2022-11-15 |
Family
ID=83951533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210962729.1A Pending CN115336746A (en) | 2022-08-11 | 2022-08-11 | Medicinal and edible composition for health preservation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115336746A (en) |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101569672A (en) * | 2008-04-29 | 2009-11-04 | 潘诚 | Golden brain powder |
| CN101850066A (en) * | 2009-11-06 | 2010-10-06 | 中山市中智药业集团有限公司 | Chinese medicinal composition granules and preparation method thereof |
| CN102302684A (en) * | 2011-09-23 | 2012-01-04 | 唐红芳 | Radix notoginseng tablets for promoting blood circulation |
| CN105596777A (en) * | 2016-01-08 | 2016-05-25 | 佛山市恒南医药科技有限公司 | Traditional Chinese medicine for dredging blood vessels and reducing blood pressure |
| CN109620854A (en) * | 2019-01-25 | 2019-04-16 | 文山高田三七中药饮片有限公司 | A kind of Radix Notoginseng granule pieces and preparation method thereof |
| CN111919939A (en) * | 2020-08-25 | 2020-11-13 | 湖北药昇中药科技有限公司 | Three-treasure tea and preparation method thereof |
| CN113041293A (en) * | 2021-04-19 | 2021-06-29 | 浏阳市中医医院 | Traditional Chinese medicine composition for treating atherosclerosis |
| CN114344414A (en) * | 2022-01-29 | 2022-04-15 | 甘肃朴森药业有限公司 | Traditional Chinese medicine composition for soothing nerves and helping sleep as well as preparation method and application thereof |
-
2022
- 2022-08-11 CN CN202210962729.1A patent/CN115336746A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101569672A (en) * | 2008-04-29 | 2009-11-04 | 潘诚 | Golden brain powder |
| CN101850066A (en) * | 2009-11-06 | 2010-10-06 | 中山市中智药业集团有限公司 | Chinese medicinal composition granules and preparation method thereof |
| CN102302684A (en) * | 2011-09-23 | 2012-01-04 | 唐红芳 | Radix notoginseng tablets for promoting blood circulation |
| CN105596777A (en) * | 2016-01-08 | 2016-05-25 | 佛山市恒南医药科技有限公司 | Traditional Chinese medicine for dredging blood vessels and reducing blood pressure |
| CN109620854A (en) * | 2019-01-25 | 2019-04-16 | 文山高田三七中药饮片有限公司 | A kind of Radix Notoginseng granule pieces and preparation method thereof |
| CN111919939A (en) * | 2020-08-25 | 2020-11-13 | 湖北药昇中药科技有限公司 | Three-treasure tea and preparation method thereof |
| CN113041293A (en) * | 2021-04-19 | 2021-06-29 | 浏阳市中医医院 | Traditional Chinese medicine composition for treating atherosclerosis |
| CN114344414A (en) * | 2022-01-29 | 2022-04-15 | 甘肃朴森药业有限公司 | Traditional Chinese medicine composition for soothing nerves and helping sleep as well as preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105031037A (en) | Health care product for conditioning qi stagnation constitution | |
| CN103519267A (en) | Honey vinegar health drink and preparation method thereof | |
| CN106418143A (en) | Composition for improving sleep and vision and application thereof | |
| CN115336746A (en) | Medicinal and edible composition for health preservation | |
| CN112273490A (en) | Hawthorn and ginger tea potion | |
| CN103751547B (en) | Chinese medicine composition of a kind of blood fat reducing and preparation method thereof | |
| CN106729190B (en) | A granule containing Chinese medicinal effective components for invigorating spleen, invigorating qi and eliminating dampness, and its preparation method | |
| CN115349632A (en) | Medicinal and edible composition for health preservation | |
| CN104825817B (en) | A kind of Chinese medicine preparation with antitumor action | |
| CN102552743A (en) | Medicinal composition for treating diabetes and preparation method thereof | |
| CN106038743A (en) | Blood pressure reducing electuary, and preparation method and application thereof | |
| CN106860495A (en) | Fat-reducing liver-protecting Chinese medicine composition | |
| CN104587304A (en) | Medicine for treating simple obesity and application of medicine | |
| CN109463625A (en) | A kind of buckwheat walnut anti-inflammatory food slug and preparation method thereof | |
| CN103585547A (en) | Series product containing Japanese polypody rhizome | |
| CN113786470B (en) | Traditional Chinese medicine composition for treating deficiency of both qi and blood, food containing traditional Chinese medicine composition and preparation method | |
| CN105685305A (en) | Medicine and food homologous medicinal tea drink capable of clearing away heat and toxic materials, cooling blood and removing blood stasis, promoting secretion of saliva or body fluid, benefiting diuresis and burning fat | |
| CN105833109B (en) | Moringa oleifera-containing composition for treating hyperglycemia and hyperlipidemia and preparation method and application thereof | |
| CA3099371A1 (en) | A new method to relief long term pain with the herbal composition. the herbal composition is corydalis yanhusuo, e zhu(curcuma kwangsiensis, rhizome), cili fruit (rosa roxburghii) extract and dl-alpha-lipoic acid, adjusting the dosages according to the causes of the pain and the situation of the patient's body | |
| CN114632063A (en) | Rheumatism pain powder for treating rheumatism | |
| CN105920393A (en) | Traditional Chinese medicine for treating epilepsy | |
| CN112569315A (en) | Medicated diet powder for resisting cancer, consolidating constitution and preventing and treating cancer | |
| CN103638330A (en) | Traditional Chinese medicine preparation for treating qi-blood deficiency type migraine and preparation method thereof | |
| CN114931610A (en) | Miao medicine for treating brain fibroma and preparation method thereof | |
| CN111000938A (en) | Sanqing powder for removing lipotoxin and sugar poison and preventing and treating diabetic complications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |